At least 14 more employees have been detained following an announcement made by the Chinese media earlier this week regarding the arrest of four GlaxoSmithKline executives in connection to corruption allegations. The Chinese police said these arrests stemmed from allegations that the drugmaker siphoned off up to 3 billion yuan ($480 million) to travel agencies for bribes to doctors and officials.
Xinhua, a Chinese news agency, claims that certain GSK employees were "suspected of offering bribes to doctors, asking them to prescribe more drugs in order to grow sales volume and in the meantime, pushing up drug prices."
This week, GSK appointed a top European executive as the new head of operations in China. Read the full story.